COSA 2013* Kate Wilson
NHMRC, Clinical Trials Centre, NSW, Australia
- This delegate is presenting an abstract at this event.
Presentations this author is a contributor to:
ICECREAM: Irinotecan Cetuximab Evaluation and the Cetuximab Response Evaluation Among Patients with G13D Mutation (#328)
3:00 PM
Eva Segelov
Posters - Trials in progress